These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2892504)

  • 1. Clinical trials of acellular pertussis vaccine in Sweden. An attempt to solve the problem of pertussis vaccination.
    Olin P
    Ann Sclavo Collana Monogr; 1986; 3(1-2):165-72. PubMed ID: 2892504
    [No Abstract]   [Full Text] [Related]  

  • 2. Japanese clinical trials with Takeda acellular pertussis vaccine.
    Kuno-Sakai H; Kimura M; Ozaki K; Isomura S; Kamiya H; Nii R; Kato T; Horiuchi K; Syukuda Y; Fujita I
    Tokai J Exp Clin Med; 1988; 13 Suppl():15-9. PubMed ID: 2908519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and serological reactions after immunization of children in Ghana, West Africa, with the Japanese acellular pertussis vaccine.
    Biritwum RB; Isomura S; Ofosu-Amaah S; Sato Y
    Dev Biol Stand; 1985; 61():539-43. PubMed ID: 2872130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A trial of acellular pertussis vaccine in hospital workers during the Cincinnati pertussis epidemic of 1993.
    Christie CD; Garrison KM; Kiely L; Gupta RK; Heubi J; Marchant CD
    Clin Infect Dis; 2001 Oct; 33(7):997-1003. PubMed ID: 11528571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and systemic immune responses to pertussis infection and cellular and acellular vaccines.
    Ashworth LA; Day A; Lambert HP; Lingham S; Lissauer T; Miller E; Robinson A; Rutter DA; Thomas MG
    Ann Sclavo Collana Monogr; 1986; 3(1-2):199-211. PubMed ID: 2892507
    [No Abstract]   [Full Text] [Related]  

  • 6. Acellular pertussis vaccines: what lies ahead?
    Wiedermann BL
    Contemp Pediatr; 1995 Sep; 12(9):25-8, 30, 32 passim. PubMed ID: 10155576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled trial of two acellular pertussis vaccines in Sweden--protective efficacy and adverse events. Ad Hoc Group for the Study of Pertussis Vaccines.
    Lancet; 1988 Apr; 1(8592):955-60. PubMed ID: 2896826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The control of pertussis--2007 and beyond.
    Halperin SA
    N Engl J Med; 2007 Jan; 356(2):110-3. PubMed ID: 17215528
    [No Abstract]   [Full Text] [Related]  

  • 9. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB
    Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis: persistent pathogen, imperfect vaccines.
    Yeh SH
    Expert Rev Vaccines; 2003 Feb; 2(1):113-27. PubMed ID: 12901603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary data from a clinical trial (phase 2) of an acellular pertussis vaccine, J-NIH-6.
    Blennow M; Granström M; Olin P; Tiru M; Jäätmaa E; Askelöf P; Sato Y
    Dev Biol Stand; 1986; 65():185-90. PubMed ID: 3549397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U.S. clinical trials with Takeda acellular pertussis vaccine.
    Stout MG
    Tokai J Exp Clin Med; 1988; 13 Suppl():21-8. PubMed ID: 2908521
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin.
    Ginnaga A; Morokuma K; Aihara K; Sakou M; Imaizumi A; Suzuki Y; Sato H; Sato Y; Ueda K; Kuno-Sakai H
    Tokai J Exp Clin Med; 1988; 13 Suppl():59-69. PubMed ID: 2908528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.
    Tapiainen T; Cherry JD; Heininger U
    Vaccine; 2005 Oct; 23(43):5106-12. PubMed ID: 16023771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Whooping cough is a risk to infants. The disease is circulating among adolescents and adults].
    Nilsson L; Von Segebaden K; Blennow M; Linde A; Uhnoo I
    Lakartidningen; 2013 Sep 11-17; 110(37):1599-602. PubMed ID: 24163932
    [No Abstract]   [Full Text] [Related]  

  • 16. Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccination.
    Olin P; Hallander HO; Gustafsson L; Barreto L; Podda A
    Dev Biol Stand; 1998; 95():211-20. PubMed ID: 9855434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of pertussis in the CSSR. IV. Immunological surveys of antibodies to pertussis and parapertussis in the Bohemian regions and in Slovakia in 1958 - 1971.
    Vysoká-Burianová B; Burian V; Maixnerová M; Prásilová K; Kríz B; Wernish Z; Zikmundová V; Kavanová M; Tĕmínová J; Richter J; Stehlik J; Paroulek J; Formánek J; Stejskalová M; Bezecná A; Bäumlová M; Zofka J; Strnad P; Zusková D; Zácek K
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(2):229-47. PubMed ID: 184206
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
    Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
    APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latest from pertussis front: Swedish vaccine.
    Marwick C
    JAMA; 1992 Aug; 268(8):958-9. PubMed ID: 1501314
    [No Abstract]   [Full Text] [Related]  

  • 20. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.